Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market Global Report 2026 Market Report Infographic Image

Published : February 2026

Pages :

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market Report 2026

Name: Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market Report 2026
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

Global Outlook – By Therapy Type (Messenger Ribonucleic Acid (mRNA)-Based Oncolytic Therapy, Small Interfering Ribonucleic Acid (siRNA)-Based Oncolytic Therapy, Micro Ribonucleic Acid (miRNA)-Based Oncolytic Therapy, Other Therapy Types), By Route Of Administration (Intravenous, Intratumoral, Other Route Of Administrations), By Application (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Melanoma, Other Applications), By End-User (Hospitals, Cancer Research Institutes, Specialty Clinics, Other End-Users) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Purchase This Report Download Sample PDF

Item added to cart!

Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market Overview

• Ribonucleic Acid (RNA)-Based Oncolytic Therapy market size has reached to $2.12 billion in 2025

• Expected to grow to $4.94 billion in 2030 at a compound annual growth rate (CAGR) of 18.4%

• Growth Driver: Growing Adoption Of Personalized Medicine Fueling The Growth Of The Market Due To Increasing Demand For Targeted And Patient-specific Treatments

• Market Trend: Innovations In mRNA-Lipid Nanoparticle Delivery Systems Boosting Market Growth

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market?

Ribonucleic acid (RNA)-based oncolytic therapy is a cancer treatment that uses engineered RNA viruses to selectively infect and kill tumor cells. These viruses replicate in cancer cells, causing their destruction and releasing tumor antigens. This also stimulates the immune system to recognize and attack remaining cancer cells, enhancing overall anti-tumor efficacy.

The main therapy types of ribonucleic acid (RNA)-based oncolytic therapy are messenger ribonucleic acid (mRNA)-based oncolytic therapy, small interfering ribonucleic acid (siRNA)-based oncolytic therapy, micro ribonucleic acid (miRNA)-based oncolytic therapy, and other therapy types. Messenger ribonucleic acid (mRNA)-based oncolytic therapy refers to the use of synthetic mRNA molecules engineered to stimulate the immune system or directly induce tumor cell death, offering a targeted and adaptable approach to cancer treatment. These therapies are administered through routes such as intravenous, intratumoral, and other methods, and are applied in breast cancer, lung cancer, colorectal cancer, prostate cancer, melanoma, and others. The key end-users include hospitals, cancer research institutes, specialty clinics, and others.

Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market Global Report 2026 Market Report bar graph

What Is The Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market Size and Share 2026?

The ribonucleic acid (rna)-based oncolytic therapy market size has grown rapidly in recent years. It will grow from $2.12 billion in 2025 to $2.51 billion in 2026 at a compound annual growth rate (CAGR) of 18.7%. The growth in the historic period can be attributed to advancements in cancer virology research, increasing understanding of tumor immunology, availability of clinical trial infrastructure, rising oncology research funding, early success of oncolytic virus studies.

What Is The Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market Growth Forecast?

The ribonucleic acid (rna)-based oncolytic therapy market size is expected to see rapid growth in the next few years. It will grow to $4.94 billion in 2030 at a compound annual growth rate (CAGR) of 18.4%. The growth in the forecast period can be attributed to increasing approvals of rna-based cancer therapies, rising demand for personalized oncology treatments, expansion of immuno-oncology pipelines, growing investment in gene and cell therapies, technological advancements in rna delivery systems. Major trends in the forecast period include increasing advancement of rna virus engineering, rising adoption of combination oncolytic therapies, growing focus on immune system activation, expansion of targeted tumor-specific rna therapies, enhanced integration of precision oncology tools.

Book your 30 minutes free consultation with our research experts

Global Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market Segmentation

1) By Therapy Type: Messenger Ribonucleic Acid (mRNA)-Based Oncolytic Therapy, Small Interfering Ribonucleic Acid (siRNA)-Based Oncolytic Therapy, Micro Ribonucleic Acid (miRNA)-Based Oncolytic Therapy, Other Therapy Types

2) By Route Of Administration: Intravenous, Intratumoral, Other Route Of Administrations

3) By Application: Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Melanoma, Other Applications

4) By End-User: Hospitals, Cancer Research Institutes, Specialty Clinics, Other End-Users

Subsegments:

1) By Messenger Ribonucleic Acid (mRNA)-Based Oncolytic Therapy: Self-Amplifying mRNA (saRNA), Non-Replicating mRNA, Circular RNA (circRNA)-Based mRNA therapy

2) By Small Interfering Ribonucleic Acid (siRNA)-Based Oncolytic Therapy: Chemically Modified siRNA, Nanoparticle-Delivered siRNA, Conjugated siRNA

3) By Micro Ribonucleic Acid (miRNA)-Based Oncolytic Therapy: miRNA Mimics, miRNA Inhibitors (Antagomirs), miRNA Aponges Or Decoys

4) By Other Therapy Types: Long Non-Coding RNA (lncRNA)-Based Therapies, Short Hairpin RNA (shRNA)-Based Therapies, Aptamer-RNA Based Oncolytic Agents

What Is The Driver Of The Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market?

The growing adoption of personalized medicine is expected to propel the growth of the RNA-based oncolytic therapy market going forward. Personalized medicine refers to medical treatments tailored to individual genetic profiles, improving efficacy and reducing adverse effects. The adoption of personalized medicine is increasing as more healthcare providers and institutions recognize the potential to enhance patient outcomes through targeted therapies and precision diagnostics. RNA-based oncolytic therapy plays a crucial role in cancer care by aligning with the growing adoption of personalized medicine to deliver targeted and patient-specific treatment approaches. For instance, in February 2024, the Personalized Medicine Coalition, a US-based advocacy group for tailored medical treatments, the FDA approved 16 new personalized treatments for rare disease patients in 2023, up from 6 in 2022. Therefore, the growing adoption of personalized medicine is driving the RNA-based oncolytic therapy market.

Key Players In The Global Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market

Major companies operating in the ribonucleic acid (rna)-based oncolytic therapy market are AstraZeneca PLC, Moderna Inc., BioNTech SE, Gritstone Bio Inc., Orna Therapeutics Inc., Strand Therapeutics Inc., Oncolytics Biotech Inc., Anima Biotech Inc., eTheRNA immunotherapies NV, Vyriad Inc., Haya Therapeutics Inc., Virogin Biotech Inc., Providence Therapeutics Holdings Inc., Sirnaomics Inc., Humane Genomics Inc., Replicate Bioscience Inc., Abogen Biosciences Inc., Chimeron Bio Inc., Aro Biotherapeutics Inc., TransCode Therapeutics Inc.

Global Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market Trends and Insights

Major companies are operating in the ribonucleic acid (RNA)-based oncolytic therapy market, focusing on developing technological advancements such as synthetic messenger RNA (mRNA) technology to enhance tumor-targeting efficiency, improve immune activation, and achieve more precise and durable cancer treatment outcomes. Synthetic messenger RNA (mRNA) technology is a biotechnology approach that designs and delivers lab-made mRNA sequences to direct cells to produce specific therapeutic proteins for disease treatment, including cancer. For instance, in June 2024, CSPC Pharmaceutical Group Limited, a China-based pharmaceutical company, received regulatory approval in China to initiate clinical trials for SYS6020, its synthetic mRNA-based cancer cell therapy. This development represents a major advancement in the country’s messenger RNA therapeutics landscape. SYS6020 employs mRNA-lipid nanoparticle technology to selectively target and eliminate myeloma cancer cells with minimal adverse effects, while also demonstrating potential applications in the treatment of certain autoimmune diseases.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market?

In June 2023, Charles River Laboratories International, Inc., a US-based contract research organization (CRO), partnered with Curigin Co., Ltd. to produce oncolytic RNAi gene therapy. With this collaboration, the aim is to advance the development and manufacturing of Curigin’s RNAi-based oncolytic gene therapies by leveraging Charles River’s CDMO expertise to support preclinical and clinical trials. Curigin Co. Ltd. is a South Korea-based biotechnology company specializing in the development of RNA interference (RNAi)-based oncolytic gene therapies for cancer treatment.

Regional Insights

North America was the largest region in the ribonucleic acid (RNA)-based oncolytic therapy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market?

The ribonucleic acid (RNA)-based oncolytic therapy market includes revenues earned by entities through services such as clinical trials, tumor targeting, immune monitoring, patient support, and treatment administration. The market value includes the value of related goods sold by the service provider or included within the service offering. The ribonucleic acid (RNA)-based oncolytic therapy market also includes sales of RNA oncolytic viruses, viral vectors, delivery systems, formulations, and diagnostic kits. Values in this market are ‘factory gate’ values; that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market Report 2026?

The ribonucleic acid (rna)-based oncolytic therapy market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the ribonucleic acid (rna)-based oncolytic therapy industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2026	$2.51 billion
Revenue Forecast In 2035	$4.94 billion
Growth Rate	CAGR of 18.7% from 2026 to 2035
Base Year For Estimation	2025
Actual Estimates/Historical Data	2020-2025
Forecast Period	2026 - 2030 - 2035
Market Representation	Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered	Therapy Type, Route Of Administration, Application, End-User
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled	AstraZeneca PLC, Moderna Inc., BioNTech SE, Gritstone Bio Inc., Orna Therapeutics Inc., Strand Therapeutics Inc., Oncolytics Biotech Inc., Anima Biotech Inc., eTheRNA immunotherapies NV, Vyriad Inc., Haya Therapeutics Inc., Virogin Biotech Inc., Providen
Customization Scope	Request for Customization
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Artificial Intelligence & Autonomous Intelligence

4.1.3 Digitalization, Cloud, Big Data & Cybersecurity

4.1.4 Industry 4.0 & Intelligent Manufacturing

4.1.5 Internet of Things (IoT), Smart Infrastructure & Connected Ecosystems

4.2. Major Trends

4.2.1 Increasing Advancement Of RNA Virus Engineering

4.2.2 Rising Adoption Of Combination Oncolytic Therapies

4.2.3 Growing Focus On Immune System Activation

4.2.4 Expansion Of Targeted Tumor-Specific RNA Therapies

4.2.5 Enhanced Integration Of Precision Oncology Tools

5. Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Cancer Research Institutes

5.3 Specialty Oncology Clinics

5.4 Academic Research Centers

5.5 Biopharmaceutical Companies

6. Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Ribonucleic Acid (RNA)-Based Oncolytic Therapy Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Ribonucleic Acid (RNA)-Based Oncolytic Therapy PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market Size, Comparisons And Growth Rate Analysis

7.3. Global Ribonucleic Acid (RNA)-Based Oncolytic Therapy Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Ribonucleic Acid (RNA)-Based Oncolytic Therapy Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Ribonucleic Acid (RNA)-Based Oncolytic Therapy Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market Segmentation

9.1. Global Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Messenger Ribonucleic Acid (mRNA)-Based Oncolytic Therapy, Small Interfering Ribonucleic Acid (siRNA)-Based Oncolytic Therapy, Micro Ribonucleic Acid (miRNA)-Based Oncolytic Therapy, Other Therapy Types

9.2. Global Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Intravenous, Intratumoral, Other Route Of Administrations

9.3. Global Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Melanoma, Other Applications

9.4. Global Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals, Cancer Research Institutes, Specialty Clinics, Other End-Users

9.5. Global Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Sub-Segmentation Of Messenger Ribonucleic Acid (mRNA)-Based Oncolytic Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Self-Amplifying mRNA (saRNA), Non-Replicating mRNA, Circular RNA (circRNA)-Based mRNA therapy

9.6. Global Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Sub-Segmentation Of Small Interfering Ribonucleic Acid (siRNA)-Based Oncolytic Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Chemically Modified siRNA, Nanoparticle-Delivered siRNA, Conjugated siRNA

9.7. Global Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Sub-Segmentation Of Micro Ribonucleic Acid (miRNA)-Based Oncolytic Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

miRNA Mimics, miRNA Inhibitors (Antagomirs), miRNA Aponges Or Decoys

9.8. Global Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Sub-Segmentation Of Other Therapy Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Long Non-Coding RNA (lncRNA)-Based Therapies, Short Hairpin RNA (shRNA)-Based Therapies, Aptamer-RNA Based Oncolytic Agents

10. Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market Regional And Country Analysis

10.1. Global Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market

11.1. Asia-Pacific Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Therapy Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market

12.1. China Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Therapy Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market

13.1. India Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Therapy Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market

14.1. Japan Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market Overview

14.2. Japan Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Therapy Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market

15.1. Australia Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Therapy Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market

16.1. Indonesia Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Therapy Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market

17.1. South Korea Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market Overview

17.2. South Korea Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Therapy Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market

18.1. Taiwan Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market Overview

18.2. Taiwan Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Therapy Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market

19.1. South East Asia Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market Overview

19.2. South East Asia Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Therapy Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market

20.1. Western Europe Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market Overview

20.2. Western Europe Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Therapy Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market

21.1. UK Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Therapy Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market

22.1. Germany Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Therapy Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market

23.1. France Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Therapy Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market

24.1. Italy Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Therapy Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market

25.1. Spain Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Therapy Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market

26.1. Eastern Europe Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market Overview

26.2. Eastern Europe Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Therapy Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market

27.1. Russia Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Therapy Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market

28.1. North America Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market Overview

28.2. North America Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Therapy Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market

29.1. USA Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market Overview

29.2. USA Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Therapy Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market

30.1. Canada Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market Overview

30.2. Canada Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Therapy Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market

31.1. South America Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market Overview

31.2. South America Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Therapy Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market

32.1. Brazil Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Therapy Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market

33.1. Middle East Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market Overview

33.2. Middle East Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Therapy Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market

34.1. Africa Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market Overview

34.2. Africa Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Therapy Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market Regulatory and Investment Landscape

36. Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market Competitive Landscape And Company Profiles

36.1. Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market Company Profiles

36.3.1. AstraZeneca PLC Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Moderna Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.3. BioNTech SE Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Gritstone Bio Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Orna Therapeutics Inc. Overview, Products and Services, Strategy and Financial Analysis

37. Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market Other Major And Innovative Companies

Strand Therapeutics Inc., Oncolytics Biotech Inc., Anima Biotech Inc., eTheRNA immunotherapies NV, Vyriad Inc., Haya Therapeutics Inc., Virogin Biotech Inc., Providence Therapeutics Holdings Inc., Sirnaomics Inc., Humane Genomics Inc., Replicate Bioscience Inc., Abogen Biosciences Inc., Chimeron Bio Inc., Aro Biotherapeutics Inc., TransCode Therapeutics Inc.

38. Global Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market

40. Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market High Potential Countries, Segments and Strategies

40.1 Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market In 2030 - Countries Offering Most New Opportunities

40.2 Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market In 2030 - Segments Offering Most New Opportunities

40.3 Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Overview Of Key Products - Product Examples

Table 2: Global Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market Attractiveness, Factor-Wise Evaluation

Table 3: Global Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Supply Chain Analysis

Table 4: Global Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Major Raw Material Providers

Table 5: Global Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Major Resource Providers

Table 6: Global Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Major Manufacturers (Suppliers)

Table 7: Global Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Major Distributors And Channel Partners

Table 8: Global Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Key Technologies & Future Trends

Table 9: Global Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Major Trends

Table 10: Global Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Major End Users

Table 11: Global Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Table 12: Global Ribonucleic Acid (RNA)-Based Oncolytic Therapy Historic Market Growth, 2020-2025, $ Billion

Table 13: Global Ribonucleic Acid (RNA)-Based Oncolytic Therapy Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Table 14: Global Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market - TAM, US$ Billion, 2025

Table 15: Global Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 16: Global Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 17: Global Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 18: Global Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 19: Global Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Sub-Segmentation Of Messenger Ribonucleic Acid (mRNA)-Based Oncolytic Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 20: Global Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Sub-Segmentation Of Small Interfering Ribonucleic Acid (siRNA)-Based Oncolytic Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 21: Global Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Sub-Segmentation Of Micro Ribonucleic Acid (miRNA)-Based Oncolytic Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 22: Global Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Sub-Segmentation Of Other Therapy Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 23: Global Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 24: Global Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 25: Asia-Pacific, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 26: Asia-Pacific, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 27: Asia-Pacific, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 28: China, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 29: China, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 30: China, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 31: India, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 32: India, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 33: India, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 34: Japan, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 35: Japan, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 36: Japan, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 37: Australia, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 38: Australia, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 39: Australia, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 40: Indonesia, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 41: Indonesia, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 42: Indonesia, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 43: South Korea, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 44: South Korea, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 45: South Korea, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 46: Taiwan, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 47: Taiwan, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 48: Taiwan, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 49: South East Asia, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 50: South East Asia, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 51: South East Asia, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 52: Western Europe, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 53: Western Europe, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 54: Western Europe, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 55: UK, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 56: UK, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 57: UK, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 58: Germany, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 59: Germany, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 60: Germany, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 61: France, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 62: France, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 63: France, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 64: Italy, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 65: Italy, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 66: Italy, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 67: Spain, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 68: Spain, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 69: Spain, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 70: Eastern Europe, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 71: Eastern Europe, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 72: Eastern Europe, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 73: Russia, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 74: Russia, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 75: Russia, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 76: North America, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 77: North America, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 78: North America, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 79: USA, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 80: USA, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 81: USA, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 82: Canada, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 83: Canada, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 84: Canada, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 85: South America, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 86: South America, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 87: South America, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 88: Brazil, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 89: Brazil, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 90: Brazil, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 91: Middle East, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 92: Middle East, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 93: Middle East, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 94: Africa, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 95: Africa, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 96: Africa, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 97: Global Ribonucleic Acid (RNA)-Based Oncolytic Therapy Key Competitor Estimated Market Shares, 2024, Percentage (%)

Table 98: Global Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market - Company Scoring Matrix

Table 99: AstraZeneca PLC Financial Performance

Table 100: Moderna Inc. Financial Performance

Table 101: BioNTech SE Financial Performance

Table 102: Gritstone Bio Inc. Financial Performance

Table 103: Orna Therapeutics Inc. Financial Performance

Table 104: Global Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Competitive Benchmarking (In USD Billions)

Table 105: Global Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Competitive Dashboard

Table 106: Global Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market Size Gain ($ Billion), 2025 – 2030 By Country

Table 107: Global, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market Size Gain ($ Billion), Segmentation By Therapy Type, 2025 – 2030

Table 108: Global, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market Size Gain ($ Billion), Segmentation By Route Of Administration, 2025 – 2030

Table 109: Global, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market Size Gain ($ Billion), Segmentation By Application, 2025 – 2030

List Of Figures

Figure 1: Global Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Overview Of Key Products - Product Examples

Figure 2: Global Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market Attractiveness, Factor-Wise Evaluation

Figure 3: Global Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Supply Chain Analysis

Figure 4: Global Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Major Raw Material Providers

Figure 5: Global Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Major Resource Providers

Figure 6: Global Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Major Manufacturers (Suppliers)

Figure 7: Global Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Major Distributors And Channel Partners

Figure 8: Global Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Key Technologies & Future Trends

Figure 9: Global Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Major Trends

Figure 10: Global Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Major End Users

Figure 11: Global Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Figure 12: Global Ribonucleic Acid (RNA)-Based Oncolytic Therapy Historic Market Growth, 2020-2025, $ Billion

Figure 13: Global Ribonucleic Acid (RNA)-Based Oncolytic Therapy Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Figure 14: Global Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market - TAM, US$ Billion, 2025

Figure 15: Global Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 16: Global Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 17: Global Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 18: Global Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 19: Global Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Sub-Segmentation Of Messenger Ribonucleic Acid (mRNA)-Based Oncolytic Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 20: Global Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Sub-Segmentation Of Small Interfering Ribonucleic Acid (siRNA)-Based Oncolytic Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 21: Global Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Sub-Segmentation Of Micro Ribonucleic Acid (miRNA)-Based Oncolytic Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 22: Global Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Sub-Segmentation Of Other Therapy Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 23: Global Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 24: Global Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 25: Asia-Pacific, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 26: Asia-Pacific, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 27: Asia-Pacific, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 28: China, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 29: China, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 30: China, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 31: India, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 32: India, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 33: India, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 34: Japan, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 35: Japan, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 36: Japan, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 37: Australia, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 38: Australia, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 39: Australia, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 40: Indonesia, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 41: Indonesia, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 42: Indonesia, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 43: South Korea, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 44: South Korea, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 45: South Korea, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 46: Taiwan, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 47: Taiwan, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 48: Taiwan, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 49: South East Asia, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 50: South East Asia, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 51: South East Asia, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 52: Western Europe, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 53: Western Europe, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 54: Western Europe, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 55: UK, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 56: UK, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 57: UK, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 58: Germany, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 59: Germany, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 60: Germany, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 61: France, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 62: France, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 63: France, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 64: Italy, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 65: Italy, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 66: Italy, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 67: Spain, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 68: Spain, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 69: Spain, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 70: Eastern Europe, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 71: Eastern Europe, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 72: Eastern Europe, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 73: Russia, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 74: Russia, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 75: Russia, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 76: North America, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 77: North America, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 78: North America, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 79: USA, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 80: USA, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 81: USA, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 82: Canada, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 83: Canada, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 84: Canada, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 85: South America, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 86: South America, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 87: South America, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 88: Brazil, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 89: Brazil, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 90: Brazil, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 91: Middle East, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 92: Middle East, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 93: Middle East, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 94: Africa, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 95: Africa, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 96: Africa, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 97: Global Ribonucleic Acid (RNA)-Based Oncolytic Therapy Key Competitor Estimated Market Shares, 2024, Percentage (%)

Figure 98: Global Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market - Company Scoring Matrix

Figure 99: AstraZeneca PLC Financial Performance

Figure 100: Moderna Inc. Financial Performance

Figure 101: BioNTech SE Financial Performance

Figure 102: Gritstone Bio Inc. Financial Performance

Figure 103: Orna Therapeutics Inc. Financial Performance

Figure 104: Global Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Competitive Benchmarking (In USD Billions)

Figure 105: Global Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Competitive Dashboard

Figure 106: Global Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market Size Gain ($ Billion), 2025 – 2030 By Country

Figure 107: Global, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market Size Gain ($ Billion), Segmentation By Therapy Type, 2025 – 2030

Figure 108: Global, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market Size Gain ($ Billion), Segmentation By Route Of Administration, 2025 – 2030

Figure 109: Global, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market Size Gain ($ Billion), Segmentation By Application, 2025 – 2030

Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

Anti-Inflammatory Biologics Market Revenue Outlook: Strategic Insights and Forecast to 2029

CAGR of 10.8% Projected for Anti-Tumor Drugs Market From 2025 to 2029

Future Demand and Leading Companies Shaping the Asthma Disease Market to 2029

Comprehensive Forecast: Asthma Therapeutics Market Share, Growth, and Opportunities Through 2029

Oncolytic Virus Therapy Market Report 2026 - Global Outlook – By Therapy Type (Herpes Simplex Virus (HSV)-Based Oncolytic Virus Therapy, Adenovirus-Based Oncolytic Virus Therapy, Reovirus, Poxviruses, Newcastle Disease V...

Nucleic Acid Based Gene Therapy Market Report 2026 - Global Outlook – By Technology (Anti-Sence and Anti-Gene, Short Inhibitory Sequences, Gene Transfer Therapy, Nucleoside Analogs, Ribozymes, Aptamers, Other Technologie...

mRNA Cancer Vaccines And Therapeutics Market Report 2026 - Global Outlook – By Type (Adeno Carcinomas, Mucinous Carcinomas, Adenosquamous Carcinomas), By Application (Cancer, Other Applications), By End User (Hospitals A...

mRNA Therapeutics Market Report 2026 - Global Outlook – By Product (Vaccines, Drugs), By Application (Infectious Diseases, Oncology, Rare Genetic Diseases, Respiratory Diseases, Other Applications), By End Use (Hospitals...

RNA Targeting Small Molecules Therapeutics Market Report 2026 - Global Outlook – By Offering (mRNA (Messenger Ribonucleic Acid) Translation Modulators, RNA (Ribonucleic Acid) Splicing Modification, Direct RNA (Ribonuclei...

Antisense & RNAi Therapeutics Market Report 2026 - Global Outlook – By Technology (RNA Interference, Antisense RNA), By Route Of Administration (Intravenous Injections, Intra-dermal Injections, Other Delivery Methods), B...

Oligonucleotide Therapy Market Report 2026 - Global Outlook – By Type (Antisense Oligonucleotide, Aptamer, Other Types), By Application (Infectious Diseases, Oncology, Neurodegenerative Disorders, Cardiovascular Diseases...

Frequently Asked Questions

How big is the Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market?

The Ribonucleic Acid (RNA)-Based Oncolytic Therapy market was valued at $2.12 billion in 2025, increased to $2.51 billion in 2026, and is projected to reach $4.94 billion by 2030.

What is the Ribonucleic Acid (RNA)-Based Oncolytic Therapy market growth?

The global Ribonucleic Acid (RNA)-Based Oncolytic Therapy market is expected to grow at a CAGR of 18.4% from 2026 to 2035 to reach $4.94 billion by 2035.

Who are the key players in Ribonucleic Acid (RNA)-Based Oncolytic Therapy market?

Some Key Players in the Ribonucleic Acid (RNA)-Based Oncolytic Therapy market Include, AstraZeneca PLC, Moderna Inc., BioNTech SE, Gritstone Bio Inc., Orna Therapeutics Inc., Strand Therapeutics Inc., Oncolytics Biotech Inc., Anima Biotech Inc., eTheRNA immunotherapies NV, Vyriad Inc., Haya Therapeutics Inc., Virogin Biotech Inc., Providence Therapeutics Holdings Inc., Sirnaomics Inc., Humane Genomics Inc., Replicate Bioscience Inc., Abogen Biosciences Inc., Chimeron Bio Inc., Aro Biotherapeutics Inc., TransCode Therapeutics Inc. .

What is the anticipated growth trend for the Ribonucleic Acid (RNA)-Based Oncolytic Therapy market?

Major trend in this market includes: Innovations In mRNA-Lipid Nanoparticle Delivery Systems Boosting Market Growth. For further insights on this market. request a sample here

Which region has the most growth potential in the Ribonucleic Acid (RNA)-Based Oncolytic Therapy market?

North America was the largest region in the ribonucleic acid (RNA)-based oncolytic therapy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ribonucleic acid (rna)-based oncolytic therapy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.